(Q6)Sep 30, 2024 | (Q3)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.53%479.74B | 3.88%243.24B | 8.34%941.17B | 8.90%719.29B | 11.20%458.95B | 13.91%234.16B | 1.83%868.69B | 1.77%660.49B | 1.55%412.73B | -0.09%205.56B |
Operating income | 4.53%479.74B | 3.88%243.24B | 8.34%941.17B | 8.90%719.29B | 11.20%458.95B | 13.91%234.16B | 1.83%868.69B | 1.77%660.49B | 1.55%412.73B | -0.09%205.56B |
Cost of sales | -2.88%-290.14B | -2.64%-146.11B | -6.66%-586.32B | -6.66%-438.23B | -8.11%-282.01B | -9.79%-142.35B | -1.90%-549.7B | -2.59%-410.87B | -2.77%-260.87B | -4.48%-129.66B |
Operating expenses | -2.88%-290.14B | -2.64%-146.11B | -6.66%-586.32B | -6.66%-438.23B | -8.11%-282.01B | -9.79%-142.35B | -1.90%-549.7B | -2.59%-410.87B | -2.77%-260.87B | -4.48%-129.66B |
Gross profit | 7.16%189.6B | 5.80%97.13B | 11.24%354.85B | 12.60%281.07B | 16.51%176.94B | 20.96%91.81B | 1.72%318.99B | 0.45%249.62B | -0.47%151.86B | -7.04%75.9B |
Selling expenses | -24.05%-65.17B | -20.89%-32.7B | -11.25%-115.14B | -9.86%-86.32B | -9.59%-52.53B | -5.74%-27.05B | 13.61%-103.5B | 15.16%-78.57B | 14.23%-47.94B | 5.39%-25.58B |
Administrative expenses | -38.02%-23.06B | -81.99%-13.28B | 0.47%-41.99B | 4.72%-27.97B | 12.19%-16.71B | 13.47%-7.3B | -32.14%-42.18B | -19.77%-29.35B | -18.59%-19.02B | -17.65%-8.43B |
Research and development expenses | -11.64%-27.56B | -27.79%-13.37B | 7.91%-52.26B | 10.95%-38.17B | 15.88%-24.68B | 26.27%-10.47B | -2.31%-56.74B | 3.72%-42.86B | -1.83%-29.34B | -4.99%-14.19B |
Depreciation and amortization | 29.92%-3.44B | 27.71%-1.79B | -59.89%-21.59B | -77.21%-19.51B | 10.40%-4.91B | 9.89%-2.48B | -15.94%-13.5B | -24.89%-11.01B | 8.35%-5.48B | 10.48%-2.75B |
Impairment and provision | ---- | ---- | -287.66%-10.52B | -287.66%-10.52B | ---2.03B | ---2.03B | 89.20%-2.71B | 89.20%-2.71B | ---- | ---- |
-Goodwill impairment | ---- | ---- | -287.66%-10.52B | -287.66%-10.52B | ---2.03B | ---2.03B | 89.20%-2.71B | 89.20%-2.71B | ---- | ---- |
Special items of operating profit | --851M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit | -6.36%71.24B | -15.30%35.99B | 12.95%113.35B | 15.83%98.59B | 51.90%76.07B | 70.35%42.49B | 44.10%100.35B | 60.83%85.11B | 9.22%50.08B | -19.14%24.94B |
Financing income | 2,347.90%17.13B | 74.94%-1.48B | 10.00%-9.96B | 80.24%-4.26B | 97.95%-762M | -209.85%-5.9B | 29.49%-11.07B | -202.67%-21.57B | -1,502.00%-37.08B | -61.92%5.37B |
Financing cost | -26.86%-4.62B | -22.65%-2.19B | -34.29%-7.95B | -37.97%-5.77B | -38.22%-3.64B | -43.41%-1.78B | -20.55%-5.92B | -12.42%-4.18B | -3.87%-2.63B | 1.82%-1.24B |
Special items of earning before tax | -144.32%-1.22B | -81.16%257M | 5.74%6.16B | -29.26%3.19B | -9.76%2.76B | 1,151.38%1.36B | -44.66%5.82B | -49.29%4.52B | -20.08%3.05B | -94.95%109M |
Earning before tax | 10.88%82.53B | -9.93%32.58B | 13.92%101.6B | 43.63%91.75B | 454.70%74.43B | 23.97%36.17B | 49.76%89.19B | -19.26%63.88B | -73.05%13.42B | -36.35%29.18B |
Tax | -47.58%-17.44B | -67.10%-10.06B | -44.89%-22.53B | -42.54%-16.81B | -48.27%-11.82B | -11.54%-6.02B | 42.01%-15.55B | 52.33%-11.79B | 47.50%-7.97B | 40.64%-5.4B |
After-tax profit from continuing operations | 3.95%65.09B | -25.32%22.52B | 7.38%79.07B | 43.88%74.94B | 1,049.44%62.61B | 26.80%30.15B | 124.95%73.64B | -4.21%52.09B | -84.26%5.45B | -35.28%23.78B |
Special items of earning after tax | 185.21%2.48B | -47.19%1.51B | 4.07%-7.74B | 46.80%-4.53B | 61.74%-2.91B | 181.90%2.85B | -156.21%-8.06B | -176.92%-8.51B | -165.59%-7.62B | -157.11%-3.48B |
Earning after tax | 13.19%67.57B | -27.21%24.02B | 8.78%71.33B | 61.58%70.41B | 2,852.24%59.7B | 62.58%33B | 39.28%65.57B | -33.41%43.58B | -104.69%-2.17B | -52.61%20.3B |
Minority profit | 64.31%-854M | 70.37%-368M | -20.35%-8.68B | -12.03%-6.23B | 45.55%-2.39B | 47.40%-1.24B | 52.47%-7.21B | 56.98%-5.56B | -1.17%-4.4B | -5.73%-2.36B |
Profit attributable to shareholders | 10.20%68.42B | -28.77%24.39B | 9.93%80.01B | 55.97%76.64B | 2,689.26%62.09B | 51.12%34.24B | 16.92%72.78B | -37.29%49.14B | -95.60%2.23B | -49.72%22.66B |
Basic earnings per share | 17.76%3.58 | -25.00%1.26 | 14.16%3.95 | 62.07%3.76 | 2,940.00%3.04 | 57.01%1.68 | 20.56%3.46 | -35.91%2.32 | -95.71%0.1 | -48.56%1.07 |
Diluted earnings per share | 16.28%3.5 | -25.30%1.24 | 13.99%3.91 | 61.04%3.72 | 2,910.00%3.01 | 56.60%1.66 | 20.77%3.43 | -35.47%2.31 | -95.65%0.1 | -48.29%1.06 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data